RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+8.88%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.2B
AUM Growth
+$4.2B
(+0.35%)
Cap. Flow
-$163M
Cap. Flow
% of AUM
-3.88%
Top 10 Holdings %
Top 10 Hldgs %
34.34%
Holding
127
New
6
Increased
35
Reduced
17
Closed
3
Top Buys
| 1 |
Humana
HUM
|
$19.5M |
| 2 |
Boston Scientific
BSX
|
$14.5M |
| 3 |
Merus
MRUS
|
$12.6M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$9.71M |
| 5 |
Agilon Health
AGL
|
$6.94M |
Top Sells
Sector Composition
| 1 | Healthcare | 97.2% |
| 2 | Consumer Staples | 1.04% |
| 3 | Industrials | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Humana
HUM
$36.5B
| $210M | 5% | 470,000 +43,500 | +10% | +$19.5M |
|
2
Immunocore
IMCR
$1.62B
| $182M | 4.32% | 3,028,410 +26,748 | +0.9% | +$1.6M |
|
3
Insulet
PODD
$23.9B
| $161M | 3.83% | 559,000 +22,250 | +4% | +$6.42M |
|
|
4
Agilon Health
AGL
$530M
| $144M | 3.42% | 8,282,500 +400,000 | +5% | +$6.94M |
|
|
BPMC
5
DELISTED
Blueprint Medicines
BPMC
| $138M | 3.29% | 2,186,672 +153,624 | +8% | +$9.71M |
|
6
argenx
ARGX
$43.6B
| $136M | 3.25% | 350,000 | – | – |
|
7
Penumbra
PEN
$10.6B
| $126M | 3% | 366,000 -67,500 | -16% | -$23.2M |
|
8
Neurocrine Biosciences
NBIX
$13.8B
| $121M | 2.87% | 1,279,500 +69,400 | +6% | +$6.54M |
|
9
Evolent Health
EVH
$1.12B
| $115M | 2.74% | 3,803,500 | – | – |
|
10
UnitedHealth
UNH
$281B
| $111M | 2.63% | 230,000 -40,000 | -15% | -$19.2M |
|
|
KRTX
11
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $107M | 2.55% | 493,527 | – | – |
|
12
Intuitive Surgical
ISRG
$170B
| $102M | 2.43% | 298,500 | – | – |
|
13
Idexx Laboratories
IDXX
$51.8B
| $97.7M | 2.32% | 194,500 -13,000 | -6% | -$6.53M |
|
14
Exact Sciences
EXAS
$8.98B
| $88.6M | 2.11% | 943,500 +2,000 | +0.2% | +$188K |
|
|
CERE
15
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $79.9M | 1.9% | 2,513,916 | – | – |
|
16
West Pharmaceutical
WST
$17.8B
| $77.3M | 1.84% | 202,000 | – | – |
|
|
SGEN
17
DELISTED
Seagen Inc. Common Stock
SGEN
| $77M | 1.83% | 400,200 | – | – |
|
18
Align Technology
ALGN
$10.3B
| $76.7M | 1.83% | 217,000 -30,350 | -12% | -$10.7M |
|
19
Agios Pharmaceuticals
AGIO
$2.19B
| $76.1M | 1.81% | 2,686,167 +24,562 | +0.9% | +$696K |
|
20
Akero Therapeutics
AKRO
$3.74B
| $72.4M | 1.72% | 1,550,754 +96,500 | +7% | +$4.51M |
|
21
Acadia Healthcare
ACHC
$2.12B
| $72.3M | 1.72% | 908,000 +47,132 | +5% | +$3.75M |
|
22
Alnylam Pharmaceuticals
ALNY
$58.5B
| $65.5M | 1.56% | 345,000 | – | – |
|
23
Ultragenyx Pharmaceutical
RARE
$2.89B
| $63.9M | 1.52% | 1,384,269 +47,868 | +4% | +$2.21M |
|
24
DexCom
DXCM
$29.5B
| $63M | 1.5% | 490,500 | – | – |
|
25
Edwards Lifesciences
EW
$47.8B
| $60.9M | 1.45% | 645,900 | – | – |
|